振东制药年度股东大会地址临时变动 股权登记日收市后通知致股东跨省奔波

Group 1 - The company announced a change in the location of the 2024 Annual General Meeting (AGM) from Shanxi to Beijing to facilitate shareholder attendance [2][3] - As of March 31, 2025, the company had 48,600 ordinary shareholders, with the record date for the AGM being May 8, 2025 [3] - The sudden change in the meeting location may catch shareholders off guard, especially those who had already planned their travel arrangements [4] Group 2 - The company reported a revenue of 2.971 billion yuan for the previous year, a year-on-year decrease of 18.06%, and a net profit attributable to shareholders of -1.329 billion yuan, a decrease of 2920.55% [4] - In the first quarter of this year, the company achieved a revenue of 755 million yuan, down 3.53% year-on-year, with a net profit of 1.1572 million yuan, a decline of 94.99% [4] - The AGM will address critical matters such as the company's 2024 profit distribution plan and the reappointment of the auditing firm for the 2025 financial report, which are vital for the company's operational stability and shareholder interests [4]